SEPN
Septerna, Inc.
NASDAQ · USHealthcareBiotechnology
$32.21-3.56%
Price as of Jul 20, 2026
SEPN profitability
Septerna, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 99.4%
- EBITDA margin
- -72.1%
- EBIT margin
- -77.1%
- Net margin
- -49.9%
- Free cash flow margin
- 148.0%
Returns
- Return on equity
- -9.5%
- Return on assets
- -6.3%
- Return on invested capital
- -13.9%
- Asset turnover
- 0.12x
Cash efficiency
- Cash from operations
- $107.9M
- Cash per share
- $7.71
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.